Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
5.13
+0.03 (0.59%)
Jun 5, 2025, 4:00 PM - Market closed
Precision BioSciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Revenue | 51.14 | 68.7 | 48.73 | 25.1 | 115.53 | 24.29 | Upgrade
|
| Revenue Growth (YoY) | -11.11% | 40.98% | 94.15% | -78.28% | 375.72% | 9.21% | Upgrade
|
| Gross Profit | 51.14 | 68.7 | 48.73 | 25.1 | 115.53 | 24.29 | Upgrade
|
| Selling, General & Admin | 35.55 | 35.3 | 39.09 | 43.34 | 43.23 | 39.41 | Upgrade
|
| Research & Development | 59.68 | 59.56 | 53.38 | 44.07 | 111.68 | 94.71 | Upgrade
|
| Operating Expenses | 95.23 | 94.86 | 92.46 | 87.41 | 154.91 | 134.11 | Upgrade
|
| Operating Income | -44.09 | -26.16 | -43.74 | -62.31 | -39.38 | -109.83 | Upgrade
|
| Interest Expense | -1.56 | -1.78 | -2.23 | -1.11 | -0.13 | - | Upgrade
|
| Interest & Investment Income | 6.42 | 6.76 | 7.69 | 3.47 | 0.21 | 0.82 | Upgrade
|
| Earnings From Equity Investments | -1.46 | -1.08 | -4.93 | -1.58 | 0.18 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 18.42 | 29.61 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -22.26 | 7.35 | -43.21 | -61.53 | -39.12 | -109.01 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.66 | 0.26 | 1.15 | -0.51 | 2.56 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.38 | -0.44 | -0.46 | -0.03 | 5.96 | - | Upgrade
|
| Asset Writedown | - | - | - | -10.84 | - | - | Upgrade
|
| Pretax Income | -21.99 | 7.17 | -42.53 | -72.91 | -30.6 | -109.01 | Upgrade
|
| Earnings From Continuing Operations | -21.99 | 7.17 | -42.53 | -72.91 | -30.6 | -109.01 | Upgrade
|
| Earnings From Discontinued Operations | - | - | -18.79 | -38.73 | - | - | Upgrade
|
| Net Income | -21.99 | 7.17 | -61.32 | -111.64 | -30.6 | -109.01 | Upgrade
|
| Net Income to Common | -21.99 | 7.17 | -61.32 | -111.64 | -30.6 | -109.01 | Upgrade
|
| Shares Outstanding (Basic) | 8 | 7 | 4 | 3 | 2 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 8 | 7 | 4 | 3 | 2 | 2 | Upgrade
|
| Shares Change (YoY) | 88.81% | 79.20% | 31.11% | 49.77% | 12.79% | 23.91% | Upgrade
|
| EPS (Basic) | -2.79 | 1.05 | -15.96 | -38.10 | -15.64 | -62.85 | Upgrade
|
| EPS (Diluted) | -2.79 | 1.04 | -15.96 | -38.10 | -15.64 | -62.85 | Upgrade
|
| Free Cash Flow | -58.74 | -58.7 | -86.07 | -49.07 | -15.91 | -92.42 | Upgrade
|
| Free Cash Flow Per Share | -7.45 | -8.53 | -22.41 | -16.75 | -8.13 | -53.28 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -86.21% | -38.08% | -89.76% | -248.26% | -34.08% | -452.25% | Upgrade
|
| Profit Margin | -42.99% | 10.43% | -125.84% | -444.80% | -26.49% | -448.86% | Upgrade
|
| Free Cash Flow Margin | -114.87% | -85.44% | -176.64% | -195.52% | -13.77% | -380.55% | Upgrade
|
| EBITDA | -41.43 | -22.76 | -36.92 | -54.51 | -30.4 | -101.05 | Upgrade
|
| EBITDA Margin | -81.01% | -33.13% | -75.77% | -217.19% | -26.31% | - | Upgrade
|
| D&A For EBITDA | 2.66 | 3.4 | 6.82 | 7.8 | 8.98 | 8.78 | Upgrade
|
| EBIT | -44.09 | -26.16 | -43.74 | -62.31 | -39.38 | -109.83 | Upgrade
|
| EBIT Margin | -86.21% | -38.08% | -89.76% | -248.26% | -34.08% | - | Upgrade
|
Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.